Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking strategy to diabetes management. These innovative drugs operate by mimicking the physiological actions of GLP-1, a hormone produced by the https://active-bookmarks.com/story20684462/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes